MABVAX THERAPEUTICS HOLDINGS, INC. — key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2017)

$0

Net Income/Loss (FY2017)

-$19.0M

Total Assets (FY2017)

$8.8M

Total Equity (FY2017)

$1.1M

Cash Flows from Operating Activities (FY2017)

-$11.0M

Source: MABVAX THERAPEUTICS HOLDINGS, INC. 10-K/A filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.